4 completed, 2 active not recruiting. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Active not recruiting 2 |
| Phase 2 | 2 | Completed 2 |
Follow COVID - 19: new trials by email Literature Review of COVID - 19 trials Research Report on COVID - 19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of COV2 Vaccine Formulation on the Ability to Generate Antibodies Against Coronavirus That Causes COVID-19 COVID-19 Vaccines - COVID - 19, SARS CoV-2 | Phase 1 | Active not recruiting | Rokote Laboratories Finland Oy | 20 | 2026-02-10 | 2026-07-22 |
| A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults GC4006A, Normal Saline - COVID - 19 | Phase 1 | Active not recruiting | GC Biopharma Corp | 72 | 2026-01-28 | 2026-07-27 |
| EFFICACY OF COLCHICINE IN IMPROVING CLINICAL OUTCOMES IN PATIENTS WITH MILD TO MODERATE COVID-19 PNEUMONIA IN LAHORE: A RANDOMIZED CONTROL TRIAL Colchicine 0.5 MG Oral Tablet - COVID - 19 | Phase 1 / Phase 2 | Completed | Zaeema Kanwal | 66 | 2025-02-24 | 2025-09-04 |
| PA-001 Ph.1 Study in Healthy and Elderly Subjects PA-001 - COVID - 19 | Phase 1 | Completed | PeptiDream Inc. | 47 | 2024-07-30 | 2026-04-09 |
| Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG SpiN-Tec MCTI UFMG, Active Comparator: Covishield® vaccine, Active Comparator: Comirnaty® vaccine - COVID - 19 | Phase 1 / Phase 2 | Completed | Federal University of Minas Gerais | 432 | 2022-11-23 | 2025-09-15 |
| Nasal Poly-ICLC (Hiltonol®) in Healthy COVID-19 Vaccinated Adults Poly-ICLC (Hiltonol®) or Placebo - COVID - 19 | Phase 1 | Completed | Oncovir, Inc. | 43 | 2021-07-21 | 2023-05-18 |
COVID-19 (6) · Coronavirus Infections (2) · Virus Diseases (2) · Communicable Diseases (1) · Respiratory Tract Infections (1)
Coronaviridae Infections (6) · Infections (6) · Lung Diseases (6) · Nidovirales Infections (6) · Pneumonia (6) · Pneumonia, Viral (6) · RNA Virus Infections (6) · Respiratory Tract Diseases (6) · Respiratory Tract Infections (5) · Coronavirus Infections (4) · Virus Diseases (4) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
COVID-19 Vaccines (1) · Colchicine (1) · Safety (1) · Saline Solution (1) · Tablets (1) · poly ICLC (1)
Federal University of Minas Gerais (1) · GC Biopharma Corp (1) · Oncovir, Inc. (1) · PeptiDream Inc. (1) · Rokote Laboratories Finland Oy (1) · Zaeema Kanwal (1)
Brazil (1) · Canada (1) · Finland (1) · Pakistan (1) · South Korea (1) · United States (1)
Andres M Salazar, MD (1) · Masato Murakami, MD (1) · Ricardo T Gazzinelli, DVM, PhD (1)
PMID 110688, PMID 11440640, PMID 16011702, PMID 16051812, PMID 16625202, PMID 18073382, PMID 18778201, PMID 19355966, PMID 19420084, PMID 19564349, PMID 20038196, PMID 20389020, PMID 20549206, PMID 20615924, PMID 21467219, PMID 22065672, PMID 22086194, PMID 22379685, PMID 23032745, PMID 25424847, PMID 26564103, PMID 26870818, PMID 27956136, PMID 28158275, PMID 29696308, PMID 30110645, PMID 30611774, PMID 31699709, PMID 31986264, PMID 32125452, PMID 32134116, PMID 32298247, PMID 32574262, PMID 32998157, PMID 371793, PMID 408923, PMID 4334380, PMID 4336643, PMID 8585749, PMID 8727138